ANIK Anika Therapeutics Inc

Anika Therapeutics Inc develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair.

$39.84  -0.64 (-1.58%)
As of 04/09/2021 15:59:44 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/06/2001
Outstanding shares:  14,329,618
Average volume:  208,893
Market cap:   $570,318,796
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    035255108
ISIN:        US0352551081
Sedol:      2035754
Valuation   (See tab for details)
PE ratio:   -23.78
PB ratio:   2.09
PS ratio:   4.37
Return on equity:   -8.80%
Net income %:   -18.38%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy